BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23264329)

  • 21. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema.
    Androudi S; Letko E; Meniconi M; Papadaki T; Ahmed M; Foster CS
    Ocul Immunol Inflamm; 2005; 13(2-3):205-12. PubMed ID: 16019680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal steroids for macular edema: the past, the present, and the future.
    Cunningham MA; Edelman JL; Kaushal S
    Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Uveitic cystoid macular edema: intravitreal triamcinolone].
    Feucht M; Sturm V; Weissmann J; Richard G; Pressmar S
    Klin Monbl Augenheilkd; 2007 Jan; 224(1):62-5. PubMed ID: 17260323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained-release steroids for the treatment of diabetic macular edema.
    Daruich A; Matet A; Behar-Cohen F
    Curr Diab Rep; 2015 Nov; 15(11):99. PubMed ID: 26395924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M; Shahrzad SS; Banifatemi M
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
    Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
    Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
    Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
    Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical review: Update on treatment of inflammatory macular edema.
    Ossewaarde-van Norel A; Rothova A
    Ocul Immunol Inflamm; 2011 Feb; 19(1):75-83. PubMed ID: 21034302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alpha 2b in the treatment of uveitic cystoid macular edema.
    Butler NJ; Suhler EB; Rosenbaum JT
    Ocul Immunol Inflamm; 2012 Apr; 20(2):86-90. PubMed ID: 22409560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
    Soheilian M; Rabbanikhah Z; Ramezani A; Kiavash V; Yaseri M; Peyman GA
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):199-206. PubMed ID: 20307215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal injection therapy in the treatment of noninfectious uveitis.
    Modorati G; Miserocchi E
    Dev Ophthalmol; 2012; 51():110-21. PubMed ID: 22517209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral effect of unilateral dexamethasone intravitreal implant in a case of noninfectious uveitic macular edema and vitritis.
    Habot-Wilner Z; Sorkin N; Goldenberg D; Goldstein M
    Retin Cases Brief Rep; 2015; 9(2):151-3. PubMed ID: 25462131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
    Angunawela RI; Heatley CJ; Williamson TH; Spalton DJ; Graham EM; Antcliffe RJ; Stanford MR
    Acta Ophthalmol Scand; 2005 Oct; 83(5):595-9. PubMed ID: 16187999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.